Publications by authors named "Cassandra Slader"

Claim this Profile
P
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.
Vip Viprakasit, Mona M Hamdy, Hoda M A Hassab, Laila M Sherief, Muneer Al-Bagshi, Cassandra Slader

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey.
Jieun Uhm, Kyoung Ha Kim, Hyewon Lee, Hawk Kim, Slader Cassandra

Blood Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Yen-Shen Lu, Keun Seok Lee, Tsu-Yi Chao, Ling-Ming Tseng, Imjai Chitapanarux, Cassandra Slader

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries.
Anna Turkina, Jianxiang Wang, Vikram Mathews, Guray Saydam, Chul Won Jung, Cassandra Slader

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Middle East observational study in metastatic soft tissue sarcoma: an epidemiological study on the treatment patterns (MOON).
Muhammad A Memon, Burcak Karaca, Rasha Aboelhassan, Mohsen Barsoum, Mustafa Erman, Cassandra Slader

J Cancer Res Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.
David M Ross, Susan Branford, John F Seymour, Anthony P Schwarer, Christopher Arthur, Cassandra Slader

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib.
Deborah L White, Jerald Radich, Simona Soverini, Verity A Saunders, Amity K Frede, Cassandra Slader

Haematologica· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring peak flow enhances adherence to monitoring in asthma.
Cassandra A Slader, Elena G Belousova, Helen K Reddel

Thorax· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine use in asthma: who is using what?
Cassandra A Slader, Helen K Reddel, Christine R Jenkins, Carol L Armour, Sinthia Z Bosnic-Anticevich

Respirology· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of awareness of need to clean CFC-free metered-dose inhalers.
Cassandra A Slader, l Helen K Reddel, Sinthia Z Bosnic-Anticevich

J Asthma· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary therapies in general practice.
Cassandra Slader

Aust Fam Physician· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis